← Back to Search

Cancer Vaccine

A for Kidney Cancer

Phase 2
Waitlist Available
Led By Greg Smith, MD
Research Sponsored by Antisoma Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Study Summary

The aim of this study is to evaluate the efficacy of AS1411 in patients with Metastatic Renal Cell Carcinoma

Eligible Conditions
  • Kidney Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
To determine the Overall Response Rate to AS1411
Secondary outcome measures
To assess pharmacodynamic markers of AS1411
To assess the pharmacokinetic profile of AS1411
To determine the safety and tolerability of two cycles of AS1411
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: AExperimental Treatment1 Intervention
AS1411 treatment
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
AGRO100
Not yet FDA approved

Find a Location

Who is running the clinical trial?

Antisoma ResearchLead Sponsor
10 Previous Clinical Trials
943 Total Patients Enrolled
Greg Smith, MDPrincipal InvestigatorSaint Francis Hospital
Harry Drabkin, MDPrincipal InvestigatorMedical University of South Carolina
1 Previous Clinical Trials
38 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
A Phase II Study of AS1411 in Renal Cell Carcinoma
2008. "A Phase II Study of AS1411 in Renal Cell Carcinoma". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00740441.
All > Renal Cell Carcinoma
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top